Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM-3

Publication Date

2026

Content Type

article

PubMed ID:

42159085

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS